Table 2:
Combination of HDAC and NF-
𝜅
B inhibitors against synovial sarcoma cells.
Timepoint (hrs)
IC
50
average
MS-275
BAY 11-7085
Combination (
μ
M)
(
μ
M)
(
μ
M)
MS-275
BAY 11
24
4.5
3.5
0.45
1.4
48
0.56
3.4
0.27
0.8